CHINA RESOURCES PHARMACEUTICAL (CRPGF)

0,5600 0,0000 (0,00%) Ab 10:23AM EDT. Markt geöffnet.

CHINA RESOURCES PHARMACEUTICAL

China Resources Building
41st Floor Room 4104–05 26 Harbour Road
Wan Chai
Hong Kong
852 2593 8991
https://www.crpharm.com

Sektor(en): Healthcare
Branche: Drug Manufacturers - Specialty & Generic
Vollzeitmitarbeiter: 72.986

Leitende Angestellte

Name	Titel	Zahlen	Ausgeübt	Geburtsjahr
Mr. Xiaosong Bai	CEO & Executive Director	496,03k	N/A	1971
Mr. Ran Tao	VP & Executive Director	405,53k	N/A	1965
Madam Rong Deng	CFO & Executive Director	N/A	N/A	1978
Ms. Lu Ge	Chief Information Officer & VP	N/A	N/A	1971
Ms. Kwai Yuk Cheng	Company Secretary	N/A	N/A	N/A
Mr. Jianjun Wu	Vice President	N/A	N/A	1972
Mr. Kai Qiu	Vice President of CR Pharma & Chairman of China Resources Boya	N/A	N/A	1969

Die Beträge haben den Stand 31. Dezember 2023 und Kompensationswerte gelten für das letzte Geschäftsjahr bis zu diesem Datum. Der Lohn umfasst Gehalt, Boni usw. „Ausgeübt“ entspricht dem Wert von Optionen, die im Lauf des Geschäftsjahrs ausgeübt werden. Währung in USD.

Beschreibung

China Resources Pharmaceutical Group Limited, an investment holding company, engages in the research and development, manufacture, distribution, and retail of pharmaceutical and other healthcare products in Mainland China and internationally. It operates through four segments: Pharmaceutical Manufacturing, Pharmaceutical Distribution, Pharmaceutical Retail, and Others. The company offers a range of chemical drugs, Chinese medicines, and v, as well as nutritional and healthcare products for various therapeutic areas, including cardiovascular and cerebrovascular, alimentary tract, metabolism and endocrine, respiratory, orthopedics, oncology, medical nutrition, gastroenterology, pediatrics, genitourinary system, cough and cold, anti-infection, dermatology, infusion solutions, etc. It provides warehousing, logistics, and other value-added pharmaceutical supply chain solutions and related services to pharmaceutical manufacturers and dispensers, such as hospitals, distributors, and retail pharmacies. In addition, the company is involved in property holding activities, as well as operates retail pharmacies under the CR Care and Teck Soon Hong brands. It distributes its products to hospitals and other medical institutions. The company was formerly known as China Resources Medications Group Limited and changed its name to China Resources Pharmaceutical Group Limited in December 2011. The company was incorporated in 2007 and is based in Wan Chai, Hong Kong. China Resources Pharmaceutical Group Limited is a subsidiary of CRH (Pharmaceutical) Limited.

Corporate Governance

CHINA RESOURCES PHARMACEUTICAL s ISS Governance QualityScore, Stand 1. Juni 2024, lautet 5. Die grundlegenden Scores sind Audit: 4, Vorstand: 6, Shareholderrechte: 8, Kompensation: 4.

Corporate-Governance-Bewertungen von Institutional Shareholder Services (ISS). Die Werte geben den Zehntelwert im Verhältnis zum Index oder zur Region an. Ein Zehntelwert von 1 zeigt geringeres Governance-Risiko, 10 höheres Governance-Risiko.